Capabilities

Capabilities

Real-World Data & Analytics

Most organizations have data—but turning it into insight is the real challenge.


We help teams identify what data matters, where it lives, how to clean it, and how to use it. Whether it's claims data, EHRs, registries, or data from wearable devices, we transform real-world information into clear, actionable evidence.


Our work supports everything from early-stage landscape assessments to post-launch effectiveness studies.


We don't just deliver numbers—we help you understand what they mean, what to do next, and how to communicate it with confidence.

Real-World Data & Analytics

Artificial Intelligence

We use AI to do what humans can’t—detect patterns at scale, extract meaning from noise, and monitor fast-moving developments in real time.


Our AI-driven solutions have supported everything from infectious disease surveillance to health policy trend tracking, always with one goal: turning complex, heterogeneous data into informed decisions.


What sets us apart?
We focus on real opportunities in healthcare, carefully matching high-quality data with the right algorithms. We don’t build AI for the hype—we build it for impact. And we understand the importance of transparency and explainability in clinical and regulatory environments.

Artificial Intelligence

Health Economics & Outcomes Research (HEOR)

You can't talk about value without evidence.


We help life sciences companies demonstrate how new interventions perform in the real world—not just in clinical trials. Our work spans cost-effectiveness analysis, comparative safety, economic modeling, and evidence synthesis.


When you're building a value story for payers, providers, or patients, we ensure your case is clear, credible, and grounded in data that stands up to scrutiny.

Health Economics & Outcomes Research (HEOR)

Market Access & Reimbursement

Great science and technology doesn’t matter if no one pays for it.


We help clients understand what it takes to gain access and get reimbursed—whether it’s navigating evolving U.S. policies like the Inflation Reduction Act or aligning with payer expectations in key global markets.


We focus on the questions that matter:

  • What's the evidence threshold?
  • How is "value" defined in this context?
  • What will this look like in real-world practice?

We don't just map the path—we help you move through it with clarity, confidence, and a strategy that’s built to succeed.

Market Access & Reimbursement

Insights and updates on RWD

Budget Impact Models: A Practical Tool for Healthcare Decision-Making
Budget Impact Models: A Practical Tool for Healthcare Decision-Making
Oct 07, 2025
Learn how Budget Impact Models help payers and HTA agencies assess short-term affordability of new healthcare treatments alongside cost-effectiveness analysis....
Read more
New White Paper: Charting the Landscape of Real-World Data in the U.S.
New White Paper: Charting the Landscape of Real-World Data in the U.S.
Oct 01, 2025
Learn how real-world data is transforming U.S. healthcare and life sciences. Our new white paper maps datasets, applications, challenges, and future directions....
Read more
Chart showing global vaccine trial trends
Polygon Health Analytics Launches Vaccine Trial Atlas: Making Clinical Trial Data Accessible
Sep 16, 2025
The vaccine research and development community has faced unprecedented challenges in recent months, including policy upheavals, leadership changes, research program cancellations, and a surge of misinformation...
Read more
View all